ZHX2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.350300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.390400E-02
Normal-vs-Stage2
3.687900E-02
Normal-vs-Stage3
1.242960E-01
Normal-vs-Stage4
2.364000E-01
Stage1-vs-Stage2
4.136800E-01
Stage1-vs-Stage3
9.532600E-01
Stage1-vs-Stage4
4.455600E-01
Stage2-vs-Stage3
5.401200E-01
Stage2-vs-Stage4
9.251600E-01
Stage3-vs-Stage4
6.135000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.162200E-02
Normal-vs-AfricanAmerican
2.454200E-01
Normal-vs-Asian
1.157990E-01
Caucasian-vs-AfricanAmerican
3.792400E-01
Caucasian-vs-Asian
9.804600E-01
AfricanAmerican-vs-Asian
5.391000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.529500E-02
Normal-vs-Female
1.817990E-02
Male-vs-Female
6.809000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.961040E-01
Normal-vs-Age(41-60Yrs)
1.114040E-01
Normal-vs-Age(61-80Yrs)
1.411620E-02
Normal-vs-Age(81-100Yrs)
1.701020E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.981200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.220200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.467800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.755620E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.061500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.512000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.451900E-02
Normal-vs-Daily Drinker
1.781860E-02
Normal-vs-Weekly Drinker
4.838300E-03
Normal-vs-Occasional Drinker
6.677900E-02
Normal-vs-Social Drinker
3.483600E-02
Non Drinker-vs-Daily Drinker
6.817000E-01
Non Drinker-vs-Weekly Drinker
2.494600E-01
Non Drinker-vs-Occasional Drinker
5.125200E-01
Non Drinker-vs-Social Drinker
9.759200E-01
Daily Drinker-vs-Weekly Drinker
3.315200E-01
Daily Drinker-vs-Occasional Drinker
2.340200E-01
Daily Drinker-vs-Social Drinker
6.990200E-01
Weekly Drinker-vs-Occasional Drinker
4.106300E-02
Weekly Drinker-vs-Social Drinker
1.945150E-01
Occasional Drinker-vs-Social Drinker
4.638000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.323400E-01
Normal-vs-Grade 2
5.022100E-02
Normal-vs-Grade 3
1.674160E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.808600E-01
Grade 1-vs-Grade 3
4.014800E-01
Grade 1-vs-Grade 4
2.323400E-01
Grade 2-vs-Grade 3
9.681600E-01
Grade 2-vs-Grade 4
5.022100E-02
Grade 3-vs-Grade 4
1.674160E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.583800E-02
Normal-vs-NonDiabetic
8.919000E-03
Diabetic-vs-NonDiabetic
3.550600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.798010E-01
Normal-vs-NoPancreatitis
1.699740E-02
Pancreatitis-vs-NoPancreatitis
2.491400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.820000E-03
Normal-vs-N1
4.134300E-02
N0-vs-N1
1.287450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.652000E-02
Normal-vs-TP53-NonMutant
3.004200E-02
TP53-Mutant-vs-TP53-NonMutant
1.018830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
